Probably not as much as if you continued to take it, but nevertheless there may be some residual benefit. It could also be the case that as these new weight loss drugs improve, people stay on them longer
"People are concerned
2020 in Scientific Reports characterized a parallel mechanism through Src-Caveolin-1-eNOS pathway activation, which integrates BPC-157's effects on vasomotor tone with its angiogenic activity in vascular research models
Levels of the indicated histone methylation modifications were measured by colorimetric multiplex assay and the relative abundance (fold change, FC) in cells reprogrammed in the presence as compared to absence of vitamin B12 is shown
Feeling light-headed whilst taking Mounjaro (tirzepatide) is a recognised side effect that can affect patients with type 2 diabetes
Patients should be aware of symptoms suggesting gallbladder disease, including right upper quadrant abdominal pain, particularly after fatty meals, and should seek medical evaluation if such symptoms occur